Long-term survival (> 10 years) of patients >60 years with induction therapy after cardiac transplantation

European Journal of Cardio-thoracic Surgery

Volumn 24, Issue 2, 2003, Pages 283-291

  Zuckermann, Andreas ^a   Dunkler, Daniela ^a   Deviatko, Elena ^a   Bodhjalian, Arthur ^a   Czerny, Martin ^a   Ankersmit, Jan ^a   Wolner, Ernst ^a   Grimm, Michael ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Age; Antibody induction therapy; Cardiac transplantation; Risk factors; Survival

Indexed keywords

CREATININE; STEROID;

ADULT; AGED; ANTIBODY INDUCTION THERAPY; ARTERIOSCLEROSIS; CANCER; CANCER INCIDENCE; CONFERENCE PAPER; CYTOMEGALOVIRUS; FEMALE; GRAFT REJECTION; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; INCIDENCE; INFECTION; KAPLAN MEIER METHOD; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; STEROID THERAPY; SURVIVAL; TREATMENT OUTCOME;

AGE FACTORS; AGED; ANTI-BACTERIAL AGENTS; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS INFECTIONS; DISEASE-FREE SURVIVAL; FEMALE; GRAFT REJECTION; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PATIENT SELECTION; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TIME FACTORS;

EID: 0042623539     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(03)00265-3     Document Type: Conference Paper

References (25)

1. Hosenpud J.D., Bennett L.E., Keck B.M., Boucek M.M., Novick R.J. The Registry of the International Society for Heart and Lung Transplantation: Eighteenth Official report - 2001. J Heart Lung Transplant. 20:(8):2001;805-815.
2. Mudge G.H., Goldstein S., Addonizio L.J., Caplan A., Mancini D., Levine T.B., Ritsch M.E. Jr, Stevenson L.W. 24th Bethesda conference: cardiac transplantation. Task Force 3: recipient guidelines/prioritization. J Am Coll Cardiol. 22:(1):1993;21-31.
3. Blanche C., Blanche D.A., Kearney B., Sandhu M., Czer L.S., Kamlot A., Hickey A., Trento A. Heart transplantation in patients seventy years of age and older: a comparative analysis of outcome. J Thorac Cardiovasc Surg. 121:(3):2001;532-541.
4. Rickenbacher P.R., Lewis N.P., Valantine H.A., Luikart H., Stinson E.B., Hunt S.A. Heart transplantation in patients over 54 years of age. Mortality, morbidity and quality of life. Eur Heart J. 18:(5):1997;870-878.
5. Billingham M.E., Cary N.R., Hammond M.E., Kemnitz J., Marboe C., McCallister H.A., Snovar D.C., Winters G.L., Zerbe A. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant. 9:(6):1990;587-593.
6. Heroux A.L., Costanzo-Nordin M.R., O'Sullivan J.E., Kao W.G., Liao Y., Mullen G.M., Johnson M.R. Heart transplantation as a treatment option for end-stage heart disease in patients older than 65 years of age. J Heart Lung Transplant. 12:(4):1993;573-578. (discussion p. 578-9).
7. Fabbri A., Sharples L.D., Mullins P., Caine N., Large S., Wallwork J. Heart transplantation in patients over 54 years of age with triple-drug therapy immunosuppression. J Heart Lung Transplant. 11:(5):1992;929-932.
8. Olivari M.T., Antolick A., Kaye M.P., Jamieson S.W., Ring W.S. Heart transplantation in elderly patients. J Heart Transplant. 7:(4):1988;258-264.
9. Fonarow G.C. How old is too old for heart transplantation? Curr Opin Cardiol. 15:(2):2000;97-103.
10. Bull D.A., Karwande S.V., Hawkins J.A., Neumayer L.A., Taylor D.O., Jones K.W., Renlund D.G., Putnam C.W. Long-term results of cardiac transplantation in patients older than sixty years. UTAH Cardiac Transplant Program. J Thorac Cardiovasc Surg. 111:(2):1996;423-427. (discussion p. 427-8).
11. Defraigne J.O., Demoulin J.C., Beaujean M.A., Delbouille M.H., Meurisse M., Limet R. Cardiac transplantation beyond 55 years of age. Transpl Int. 3:(2):1990;59-61.
12. Robin J., Ninet J., Tronc F., Bonnefoy E., Neidecker J., Boissonat P., Champsaur G. Long-term results of heart transplantation deteriorate more rapidly in patients over 60 years of age. Eur J Cardiothorac Surg. 10:(4):1996;259-263.
13. Borkon A.M., Muehlebach G.F., Jones P.G., Bresnahan D.R. Jr, Genton R.E., Gorton M.E., Long N.D., Magalski A., Porter C.B., Reed W.A., Rowe S.K. An analysis of the effect of age on survival after heart transplant. J Heart Lung Transplant. 18:(7):1999;668-674.
14. Bourge R.C., Naftel D.C., Costanzo-Nordin M.R., Kirklin J.K., Young J.B., Kubo S.H., Olivari M.T., Kasper E.K. Pretransplantation risk factors for death after heart transplantation: a multiinstitutional study. The Transplant Cardiologists Research Database Group. J Heart Lung Transplant. 12:(4):1993;549-562.
15. Zuckermann A.O., Ofner P., Holzinger C., Grimm M., Mallinger R., Laufer G., Wolner E. Pre- and early postoperative risk factors for death after cardiac transplantation: a single center analysis. Transpl Int. 13:(1):2000;28-34.
16. Renlund D.G., Gilbert E.M., O'Connell J.B., Gay W.A. Jr, Jones K.W., Burton N.A., Doty D.B., Karwande S.V., Dewitt C.W., Menlove R.L. Age-associated decline in cardiac allograft rejection. Am J Med. 83:(3):1987;391-398.
17. Goodwin J.S., Searles R.P., Tung K.S. Immunological responses of healthy elderly population. Clin Exp Immunol. 48:(2):1982;403-410.
18. Camargo L.F., Uip D.E., Simpson A.A., Caballero O., Stolf N.A., Vilas-Boas L.S., Pannuti C.S. Comparison between antigenemia and a quantitative-competitive polymerase chain reaction for the diagnosis of cytomegalovirus infection after heart transplantation. Transplantation. 71:(3):2001;412-417.
19. Martin D.F., Sierra-Madero J., Walmsley S., Wolitz R.A., Macey K., Georgiou P., Robinson C.A., Stempien M.J. A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis. N Engl J Med. 346:(15):2002;1119-1126.
20. Swinnen L.J., Costanzo-Nordin M.R., Fisher S.G., O'Sullivan E.J., Johnson M.R., Heroux A.L., Dizikes G.J., Pifarre R., Fisher R.I. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal anitbody OKT3 in cardiac transplant recipients. N Engl J Med. 323:1990;1723.
21. Opelz G., Henderson R. Incidence of non Hodkin lymphoma in kidney and heart transplant recipients. Lancet. 342:1993;1514.
22. Costanzo M.R., Naftel D.C., Pritzker M.R., Heilman J.K. 3rd, Boehmer J.P., Brozena S.C., Dec G.W., Ventura H.O., Kirklin J.K., Bourge R.C., Miller L.W. Heart transplant coronary artery disease detected by coronary angiography: a multi-institutional study of preoperative donor and recipient risk factors. J Heart Lung Transplant. 17:1998;744-753.
23. Zuckermann A.O., Grimm M., Czerny M., Ofner P., Ullrich R., Ploner M., Wolner E., Laufer G. Improved long-term results with thymoglobuline induction therapy after cardiac transplantation: a comparison of two different rabbit-antithymocyte globulines. Transplantation. 69:(9):2000;1890-1898.
24. Glotz D., Antoine A., Pegaz B., Duboust A., Bariety J. Thymoglobuline induction nullifies the effect of cold ischemia time and delayed graft function on short and long-term kidney graft survival. Transplantation. 67:(9):1999;S603.
25. Zuckermann A., Ploner M., Czerny M., Keziban U., Birsan T., Laufer G., Wolner E., Grimm M. Low incidence of graft arteriosclerosis after cardiac transplantation: risk factor analysis for patients with induction therapy. Transplant Proc. 34:(5):2002;1869.